Aravive To Present Updated Data From Phase 1b Trial Of Batiraxcept
ravive, Inc. (NASDAQ:ARAV, ", the Company", )))), a late clinical-stage oncology company developing targeted therapeutics to treat metastatic disease, today announced the presentation of updated results from its